BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Handelsbanken Fonder AB's Holding History (CIK: 0001398318)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 45,900 Value ($000) $0 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 45,900 Value ($000) $0 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 35,500 Value ($000) $0 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 35,500 Value ($000) $0 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 35,500 Value ($000) $0 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 35,500 Value ($000) $0 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 27,100 Value ($000) $341 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 35,700 Value ($000) $378 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 35,700 Value ($000) $580 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 47,100 Value ($000) $652 Avg Close $13.23 Range $10.72 - $15.77
Q3 2021
Shares 65,700 Value ($000) $944 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 59,500 Value ($000) $941 Avg Close $13.59 Range $9.23 - $17.74